Friday, August 19, 2011
That is, if it ever happens as originally envisioned. Confusion and questions reign, even as health care costs continue to escalate.
What data standards will payers — Medicaid and private health insurance plans, in particular — want to see from comparative effectiveness research? When will they want to see the data? How big of a clinical difference between one drug and a competitor’s drug will be needed to get payers to cover all or a portion of its use? And how big of an impact will such studies have on the bottom line?